Vitamin Biosynthesis as an Antifungal Target

Area of Science:

• Mycology
• Medicinal Chemistry
• Biochemistry

Background:

• Increasing numbers of immunosuppressed patients necessitate new antifungal treatments.
• Existing antifungals face limitations in efficacy and growing resistance.
• Targeting essential fungal metabolic pathways absent in humans is a key strategy.

Purpose of the Study:

• To review vitamin biosynthetic pathways as potential sources for novel antifungal drug targets.
• To identify specific vitamin pathways that are rich in druggable targets.
• To assess the feasibility of developing new antifungal classes based on these pathways.

Main Methods:

• Review of existing literature on fungal vitamin biosynthesis.
• Development and application of ranking criteria to evaluate potential drug targets.
• Analysis of recent advances in drug design and fungal genomics.

Main Results:

• Vitamin A-E and K biosynthesis pathways were evaluated as antifungal targets.
• Vitamin B2 (riboflavin), B5 (pantothenic acid), and B9 (folate) pathways were identified as particularly promising.
• These pathways contain multiple targets suitable for antifungal drug development.

Conclusions:

• Fungal vitamin biosynthesis pathways represent a rich source for novel antifungal drug discovery.
• Targeting riboflavin, pantothenic acid, and folate synthesis offers a viable strategy for new antifungal classes.
• Advances in drug design and genomics support renewed investigation of these pathways.